MAPT and Alzheimer disease: In addition to these global glycosylation changes, phosphorylated tau (p-tau)-containing structures such as neurofibrillary tangles (NFTs) and granulovacuolar degenerations (GVDs) have been shown to be hypersialylated in Alzheimer’s disease hippocamp, while amyloid plaque cores remain unsialylated.